Position in BHC
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$352,051
-$1,654,745 QoQ
Shares Held
71,410
-80.8% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#101
of 220 holders
Holding Since
Mar 2023
4 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Lido Advisors, LLC holds $12,595,878 across 15 Drug Manufacturers - Specialty & Generic names. BHC ranks #12 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
49,202 | $5,458,469 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,812 | $981,795 | |
| 3 | AQST |
Aquestive Therapeutics, Inc.
|
215,316 | $895,714 | |
| 4 | HROW |
Harrow, Inc.
|
16,489 | $700,287 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
20,469 | $693,489 | |
| 6 | VTRS |
Viatris Inc
|
40,486 | $642,917 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
13,628 | $559,156 | |
| 8 | ZTS |
Zoetis Inc.
|
7,722 | $554,901 |
All Filings in BHC
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $352,051 | 71,410 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,006,796 | 371,629 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,582,821 | 371,629 | Shares | Sole | 2026-02-10 | |
| 2023-03-31 | $156,775 | 19,355 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||